767 related articles for article (PubMed ID: 11331952)
21. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
[TBL] [Abstract][Full Text] [Related]
22. pRB2/p130 target genes in non-small lung cancer cells identified by microarray analysis.
Russo G; Claudio PP; Fu Y; Stiegler P; Yu Z; Macaluso M; Giordano A
Oncogene; 2003 Oct; 22(44):6959-69. PubMed ID: 14534545
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical staining of GLUT1 in benign, hyperplastic, and malignant endometrial epithelia.
Wang BY; Kalir T; Sabo E; Sherman DE; Cohen C; Burstein DE
Cancer; 2000 Jun; 88(12):2774-81. PubMed ID: 10870060
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclin D1 in normal, hyperplastic and neoplastic endometrium and its correlation with Ki-67 and clinicopathological variables.
Ozuysal S; Oztürk H; Bilgin T; Filiz G
Arch Gynecol Obstet; 2005 Feb; 271(2):123-6. PubMed ID: 14740230
[TBL] [Abstract][Full Text] [Related]
25. Poly(ADP-ribose) polymerase (PARP) and DNA-fragmentation factor (DFF45): expression and correlation in normal, hyperplastic and neoplastic endometrial tissues.
Brustmann H
Pathol Res Pract; 2007; 203(2):65-72. PubMed ID: 17258405
[TBL] [Abstract][Full Text] [Related]
26. Increased expression of transforming growth factor beta isoforms and basic fibroblast growth factor in complex hyperplasia and adenocarcinoma of the endometrium: evidence for paracrine and autocrine action.
Gold LI; Saxena B; Mittal KR; Marmor M; Goswami S; Nactigal L; Korc M; Demopoulos RI
Cancer Res; 1994 May; 54(9):2347-58. PubMed ID: 8162580
[TBL] [Abstract][Full Text] [Related]
27. Who is the boss in the retinoblastoma family? The point of view of Rb2/p130, the little brother.
Paggi MG; Giordano A
Cancer Res; 2001 Jun; 61(12):4651-4. PubMed ID: 11406530
[TBL] [Abstract][Full Text] [Related]
28. Endometrial carcinoma associated with hyperplasia--immunohistochemical study of angiogenesis and p53 expression.
Kaku T; Kamura T; Hirakawa T; Sakai K; Amada S; Kobayashi H; Nakano H
Gynecol Oncol; 1999 Jan; 72(1):51-5. PubMed ID: 9889029
[TBL] [Abstract][Full Text] [Related]
29. p53lyn and p56lyn: a new signaling pathway in human endometrium and endometrial adenocarcinomas.
Couchman GM; Bentley R; Tsao MS; Raszmann K; McLachlan JA; Walmer DK
J Soc Gynecol Investig; 1997; 4(2):103-9. PubMed ID: 9101470
[TBL] [Abstract][Full Text] [Related]
30. Characterization of alterations of Rb2/p130 tumor suppressor in all-trans-retinoic acid resistant SK-OV3 ovarian carcinoma cells.
Fields AL; Soprano DR; Soprano KJ
J Cell Physiol; 2008 Oct; 217(1):77-85. PubMed ID: 18446820
[TBL] [Abstract][Full Text] [Related]
31. Genetic alterations disrupting the nuclear localization of the retinoblastoma-related gene RB2/p130 in human tumor cell lines and primary tumors.
Cinti C; Claudio PP; Howard CM; Neri LM; Fu Y; Leoncini L; Tosi GM; Maraldi NM; Giordano A
Cancer Res; 2000 Jan; 60(2):383-9. PubMed ID: 10667591
[TBL] [Abstract][Full Text] [Related]
32. Loss of pRb2/p130 expression is associated with unfavorable clinical outcome in lung cancer.
Caputi M; Groeger AM; Esposito V; De Luca A; Masciullo V; Mancini A; Baldi F; Wolner E; Giordano A
Clin Cancer Res; 2002 Dec; 8(12):3850-6. PubMed ID: 12473599
[TBL] [Abstract][Full Text] [Related]
33. The role of pRb2/p130 protein in diagnosing lung carcinoma on fine needle aspiration biopsies.
Minimo C; Bibbo M; Claudio PP; De Luca A; Giordano A
Pathol Res Pract; 1999; 195(2):67-70. PubMed ID: 10093823
[TBL] [Abstract][Full Text] [Related]
34. bcl-2 expression and the development of endometrial carcinoma.
Chhieng DC; Ross JS; Ambros RA
Mod Pathol; 1996 Apr; 9(4):402-6. PubMed ID: 8729980
[TBL] [Abstract][Full Text] [Related]
35. Parathyroid hormone-related peptide (PTH-rp) in normal, hyperplastic and malignant endometrial tissue: an immunohistochemical analysis.
Mylonas I; Makovitzky J; Shabani N; Richter DU; Jeschke U; Briese V; Friese K
Anticancer Res; 2005; 25(3A):1633-8. PubMed ID: 16033073
[TBL] [Abstract][Full Text] [Related]
36. Endometrial TIMP-4 mRNA is high at midcycle and in hyperplasia, but down-regulated in malignant tumours. Coordinated expression with MMP-26.
Pilka R; Domanski H; Hansson S; Eriksson P; Casslén B
Mol Hum Reprod; 2004 Sep; 10(9):641-50. PubMed ID: 15273280
[TBL] [Abstract][Full Text] [Related]
37. Expression of cyclin A in endometrial adenocarcinoma and its correlation with proliferative activity and clinicopathological variables.
Kyushima N; Watanabe J; Hata H; Jobo T; Kameya T; Kuramoto H
J Cancer Res Clin Oncol; 2002 Jun; 128(6):307-12. PubMed ID: 12073048
[TBL] [Abstract][Full Text] [Related]
38. Matrix metalloproteinase-26 (matrilysin-2) expression is high in endometrial hyperplasia and decreases with loss of histological differentiation in endometrial cancer.
Pilka R; Norata GD; Domanski H; Andersson C; Hansson S; Eriksson P; Casslén B
Gynecol Oncol; 2004 Sep; 94(3):661-70. PubMed ID: 15350356
[TBL] [Abstract][Full Text] [Related]
39. Inhibin (10.7 kD prostatic peptide) in normal, hyperplastic, and malignant human endometria: an immunohistochemical study.
Teni TR; Sampat MB; Sheth NA
J Pathol; 1992 Sep; 168(1):35-40. PubMed ID: 1453268
[TBL] [Abstract][Full Text] [Related]
40. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
